We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
(-8.2%)
Cap. Flow
-$614M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$113M |
| 2 |
Intel
INTC
|
+$61.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$25.3M |
| 4 |
Clorox
CLX
|
+$25.2M |
| 5 |
TJX Companies
TJX
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$107M |
| 2 |
Apple
AAPL
|
+$71.8M |
| 3 |
Travelers Companies
TRV
|
+$27.6M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$27.4M |
| 5 |
American Express
AXP
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.7% |
| 2 | Financials | 10.88% |
| 3 | Technology | 9.76% |
| 4 | Communication Services | 9.34% |
| 5 | Consumer Staples | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
FirstEnergy
FE
$28.9B
| $2.11M | 0.06% |
66,618
-157,766
| -70% | -$4.96M |
|
277
Ovintiv
OVV
$17.5B
| $2.09M | 0.06% |
82,617
+3,165
| +4% | +$116K |
|
278
PNC Financial Services
PNC
$100B
| $2.08M | 0.06% |
21,818
+2,411
| +12% | +$224K |
|
|
AGEN
279
Agenus
AGEN
$249M
| $2.08M | 0.06% |
23,320
| – | – |
|
280
Telus
TU
$16B
| $2.07M | 0.06% |
150,564
-1,350
| -0.9% | -$21K |
|
281
T. Rowe Price
TROW
$25B
| $2.03M | 0.05% |
28,449
+1,717
| +6% | +$126K |
|
282
Kroger
KR
$34.8B
| $2.03M | 0.05% |
48,542
-5,175
| -10% | -$201K |
|
283
Netflix
NFLX
$292B
| $2.02M | 0.05% |
176,720
-4,970
| -3% | -$56.8K |
|
|
SWN
284
DELISTED
Southwestern Energy Company
SWN
| $2.01M | 0.05% |
282,187
-8,943
| -3% | -$87.6K |
|
285
Equity Residential
EQR
$25.4B
| $2M | 0.05% |
24,554
+4,914
| +25% | +$388K |
|
286
Agilent Technologies
A
$39.1B
| $1.93M | 0.05% |
46,251
-39,605
| -46% | -$1.53M |
|
|
SCG
287
DELISTED
Scana
SCG
| $1.92M | 0.05% |
+31,751
| New | +$1.86M |
|
288
Walmart Inc
WMT
$871B
| $1.92M | 0.05% |
93,873
-17,409
| -16% | -$349K |
|
289
PTC Therapeutics
PTCT
$6.37B
| $1.91M | 0.05% |
59,000
-15,000
| -20% | -$441K |
|
|
AVDL
290
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.9M | 0.05% |
155,600
+25,000
| +19% | +$390K |
|
|
INFI
291
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.89M | 0.05% |
240,900
| – | – |
|
292
Canadian Natural Resources
CNQ
$96.9B
| $1.89M | 0.05% |
179,531
-55,448
| -24% | -$619K |
|
|
EGN
293
DELISTED
Energen
EGN
| $1.87M | 0.05% |
45,711
+1,300
| +3% | +$71.2K |
|
|
CTIC
294
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.86M | 0.05% |
151,500
| – | – |
|
|
LNKD
295
DELISTED
LinkedIn Corporation
LNKD
| $1.86M | 0.05% |
8,261
-295
| -3% | -$67K |
|
296
Cognizant
CTSH
$21.5B
| $1.85M | 0.05% |
30,894
+2,237
| +8% | +$144K |
|
297
Conagra Brands
CAG
$7.07B
| $1.83M | 0.05% |
55,732
-4,269
| -7% | -$136K |
|
|
MACK
298
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.82M | 0.05% |
29,284
| – | – |
|
299
TC Energy
TRP
$73.5B
| $1.82M | 0.05% |
55,923
+2,384
| +4% | +$78.9K |
|
|
ONCE
300
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.81M | 0.05% |
+40,000
| New | +$2.1M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2015 Portfolio in Review
As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.
- Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
- Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
- Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
- Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
- Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
- Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
- Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.
Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.